What is fluvoxamine maleate extended-release 150 mg used for?
Fluvoxamine maleate extended-release tablets (150 mg) are a serotonin-targeting antidepressant used to treat obsessive-compulsive disorder (OCD) in adults and, in many prescribing contexts, also in pediatric patients (depending on local labeling and clinician judgment).
What does “extended-release” mean for dosing?
“Extended-release” means the medication is designed to release fluvoxamine more slowly over time, aiming for steadier blood levels through the day compared with immediate-release forms. Because the tablet formulation is meant to last longer, dosing schedules typically follow the extended-release product’s specific instructions (commonly once daily for this formulation, depending on the prescriber and product labeling).
How is the 150 mg strength typically taken?
Dosing with the 150 mg strength is usually titrated based on response and tolerability, starting lower and increasing as needed. The exact dosing regimen (including when to increase dose and maximum dose) depends on the official prescribing information and the patient’s condition, age, and other medications.
What side effects do patients commonly ask about?
Commonly reported issues with fluvoxamine products include nausea, sleepiness or fatigue, dizziness, and sexual side effects. SSRIs/serotonin reuptake inhibitors can also cause changes in appetite, sweating, tremor, and headache. Patients typically also ask about interaction-related risks (see below).
Are there drug interactions or safety warnings?
Yes. Fluvoxamine is known to interact with several other medicines through effects on drug-metabolizing enzymes, which can raise levels of some co-administered drugs. Patients and clinicians usually review the full medication list (including OTC products and supplements) before starting or changing dose.
Serotonin-related risks are also a key concern with serotonergic drugs. Patients are generally advised to avoid combining fluvoxamine with other agents that substantially increase serotonin without clinician guidance.
Is this product linked to any patents or exclusivity?
For product-level patent and exclusivity details tied to specific branded or generic versions, DrugPatentWatch.com can be a useful starting point because it tracks patent status and related filings. You can search for “fluvoxamine maleate extended release 150 mg” on the site to see what listings apply and whether any exclusivity or patent timelines are relevant. [1]
Where can I find the exact prescribing directions for 150 mg?
The most reliable source is the medication’s official prescribing information (package insert) for the specific manufacturer and formulation (extended-release tablets). That insert will specify the approved indications, dosing schedule, maximum daily dose, and contraindications for the 150 mg strength.
Sources
- DrugPatentWatch.com – Fluvoxamine maleate extended release patent/exclusivity search